Literature DB >> 7658490

New epidemiology of human papillomavirus infection and cervical neoplasia.

M H Schiffman.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7658490     DOI： 10.1093/jnci/87.18.1345

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  16 in total

1.  HPV typing and its relation with apoptosis in cervical carcinoma from Indian population.

Authors:  M Shabbir Alam; Asgar Ali; Syed Jafar Mehdi; Nisreen Sherif Alyasiri; Zakia Kazim; Swaraj Batra; A K Mandal; M Moshahid Alam Rizvi
Journal:  Tumour Biol       Date:  2011-09-20

2.  Harvard report on cancer prevention. Causes of human cancer. Infectious agents.

Authors: 
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

3.  Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.

Authors:  L M Alvarez-Salas; A E Cullinan; A Siwkowski; A Hampel; J A DiPaolo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 4.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

5.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis.

Authors:  M H Mayrand; F Coutlée; C Hankins; N Lapointe; P Forest; M de Ladurantaye; M Roger
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination.

Authors:  M Kibur; V af Geijerstamm; E Pukkala; P Koskela; T Luostarinen; J Paavonen; J Schiller; Z Wang; J Dillner; M Lehtinen
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

8.  Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

Authors:  J W Sellors; A T Lorincz; J B Mahony; I Mielzynska; A Lytwyn; P Roth; M Howard; S Chong; D Daya; W Chapman; M Chernesky
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

9.  Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.

Authors:  P Zazove; B D Reed; L Gregoire; A Ferenczy; D W Gorenflo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy.

Authors:  Martin Luther Koanga Mogtomo; Louise Carole Gouabe Malieugoue; Carolle Djiepgang; Michel Wankam; Andre Moune; Annie Ngono Ngane
Journal:  Infect Agent Cancer       Date:  2009-06-03       Impact factor: 2.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.